Dr. Charles David Sr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 S Shoop Ave, Wauseon, OH 43567 Phone: 419-335-2015 |
Dr. James P Lewis, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 S Shoop Ave, Wauseon, OH 43567 Phone: 419-330-2605 Fax: 419-330-2649 |
News Archive
Scientists in Brazil have imaged elderly female yoga practitioners' brains and found they have greater cortical thickness in the left prefrontal cortex, in brain areas associated with cognitive functions like attention and memory.
The National Multiple Sclerosis Society has provided a grant to a Wayne State University School of Medicine professor to explore a new model of MS pathology.
The likelihood of treatment success of 48 wk peg-interferon (PEG-IFN) plus ribavirin (RBV) therapy for chronic hepatitis C may be predicted by viral kinetics on therapy. In particular, recent studies have shown that sustained virological response (SVR) can be predicted by a rapid virological response (RVR), and an early virological response (EVR).
Pfizer Inc. and Medivation, Inc. today announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine) in patients with Alzheimer's disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function.
A new study by researchers at the Universities of Montana, Carleton, and North Carolina, and the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, heightens concerns over the detrimental impact of the apolipoprotein E (APOE) ε4 allele - the most prevalent genetic risk for Alzheimer's disease - upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens.
› Verified 7 days ago